BPGbio: Fusing Patient-Driven Innovation With Causal AI

Biotech BPGbio applies causal AI to generate insights from samples from what the CEO says is one of the world's largest biobanks. With several promising late-stage programs, its platform seems to be yielding fruit.

(Shutterstock)

More from Innovation

More from New Science